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Executive summary 
 
Background 
 
Crop varieties have long been subject to steady improvement by selection of better-
performing variants. The rate of improvement increased when Mendel’s principles of genetics 
were applied to plant breeding early last century. These innovations underpinned increases in 
yields worldwide, and particularly contributed to the “green revolution” which prevented 
starvation in Asia and Central/South America, through the introduction of improved 
husbandry and high yielding varieties of wheat, rice and maize. 
 
Continued innovation in crop breeding is required for food security in the face of a growing 
population, climate change and the need to minimise the environmental impact of agriculture. 
There are several innovative technologies to support crop breeding in meeting this challenge, 
but one of them, involving the use of GM crops, is controversial. Plant breeding depends on 
the capacity to select new useful variation. GM methods enable plant breeders to exploit 
additional variation that could not have been introduced by sexual hybridisation of two 
parental plants. GM crops were developed thirty years ago, and first grown commercially in 
the USA in 1994 (FlavrSavr tomato), and in Europe in 1998 (Bt Maize in Spain). They are 
now being grown on an increasing scale by farmers in both developed and developing 
countries. Nevertheless, there is still opposition to cultivation of GM crops in Europe and 
elsewhere. 
 
At the request of the Council of Science and Technology, this paper considers the recent 
developments in the science of GM crops since the Royal Society published its report 
‘Reaping the Benefits – Sustainable Intensification of Global Agriculture’ in 2009, which 
concluded GM crops (alongside other methods) have an important role to play in sustainable 
and productive agriculture globally. Since then, other more extensive studies have come to a 
similar conclusion (Foresight, 2010). 
 
This paper comprises four sections. Section 1 summarises the findings of previous reviews 
that have assessed the impact, benefits, and trends of the cultivation of first generation GM 
crops worldwide. Section 2 reviews the potential applications of GM technologies in the 
research pipeline, and contributions that could be made by GM crops for UK, European and 
global agriculture if there were a more permissive regulatory and political process in Europe 
and elsewhere. Section 3 considers safety and risk assessment by reviewing the existing 
regulatory process in the EU and elsewhere, and exploring the consequences. Section 4 draws 
together the conclusions from Sections 1 – 3, with recommendations for potential actions that 
would allow a safe and sustainable agriculture to use GM crop varieties for the benefit of the 
farmer, the consumer and the environment. 
 
Experience of GM crop cultivation 
 
GM crops were first introduced in the USA in 1994, and are now grown in 28 countries 
worldwide. The acreage under GM cultivation is doubling every five years and now accounts 
for some 12% of global arable land. Most of the present GM crop acreage is maize, soybean, 
cotton and rapeseed (canola), with 81% of the global acreage of both soybean and cotton 
sown to GM varieties. The last crop to benefit from GM technology has been sugarbeet, with 
a herbicide resistant variety introduced in the USA in 2012, and now accounting for around 
95% of the crop grown. The two principal traits introduced into GM crops are glyphosate 
herbicide resistance and Bt insect resistance. Other traits include drought tolerance in maize 
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(recently commercialised in the USA), virus resistance in papaya, flower colour in carnations 
and roses, and insect resistance in poplar trees. 
 
The existing GM crops make it easier for farmers to control weeds or insects, by reducing not 
only the amount of chemical pesticides applied, but also the amount of diesel used for tractors 
to apply the pesticides. This can generate increased income for farmers, for example 
cumulatively since 1996, GM insect resistant varieties have added an estimated $25.8 billion 
to the income of global maize farmers, and 11.6% to the global value of the cotton crop. 
Herbicide tolerant crops allow seeds to be drilled into an unploughed field preserving soil 
structure and water retention, and preventing soil erosion. Once the seeds germinate, 
herbicides can be applied allowing the crop to grow without competition from weeds. The 
reduction in use of chemicals and soil tillage, also contribute to a lower carbon footprint and 
the reduction in greenhouse gas emissions.  
 
The development of disease and insect resistant GM crops has been particularly successful. 
The GM virus resistant variety of papaya has allowed papaya to be cultivated again in Hawaii 
in regions where previously the crop could not be grown because of a virus disease. 
Protection of crops against the damage caused by viral, fungal and bacterial diseases, offers 
not only increased yields but also lower costs of crop protection, with environmental benefits 
through a lower carbon footprint from less chemical application. In addition, there will be less 
damage to non-target organisms compared with the use of chemicals, because the GM traits 
are normally specific for the pest or pathogen, whereas crop protection chemicals may affect 
beneficial organisms as well as the intended target.  
 
It is likely that many more GM crops will be cultivated in the USA and other countries, with 
more permissive regulatory systems combined with a supportive political system. In the USA, 
between 500 – 1,000 field trial applications are approved per annum and 96 applications for 
commercialisation have been approved since 1990. Several North and South America 
countries have followed the USA. In contrast, in Europe there is only one GM crop approved 
for commercial cultivation, a Bt-insect-resistant maize. The total area of GM maize grown in 
the EU in 2012 was 129,000 hectares, of which more than 90% was grown in Spain. There are 
few commercial releases of GM crops in Africa (principally in South Africa) (IFPRI 
(International Food Policy Research Institute) 2013), while in Asia, there are several 
countries, including China, that have adopted GM crops with varying degrees of enthusiasm. 
 
Although less than 0.1% of the global acreage of GM crops is cultivated in the EU, more than 
70% of EU animal protein feed requirements are imported as GM crop products.  
 
New scientific developments over the last five years 
 
The potential for new GM crop varieties is likely to increase greatly, as combining genetics 
with high throughput genome sequencing reveals genes for important traits and mechanisms 
that could be moved from one plant species to another. The next generation of GM crops is 
expected to be improved not only by transfer of genetic elements between crop species but 
also from diverse organisms into crops.  
 
The first generation of GM crops were developed with transgenes for the new trait integrated 
randomly into the plant genome, so that many breeding lines had to be tested to select those 
with stable expression of the new trait, from those expressing the trait at low levels or 
inconsistently. However in recent years, spectacular advances in basic science have led to new 
methods for transferring genes into defined locations in the recipient crop plant genome, 
allowing their expression to be more consistent. These methods also allow inactivation of 
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genes that are deleterious for crops and their products, and for the insertion of multiple genes 
into a single location. 
 
In the short and medium term, there are many emerging GM traits with the potential for 
increasing photosynthetic efficiency, nitrogen use efficiency, aluminium tolerance, salinity 
tolerance and phosphate use efficiency in crop plants. These new GM traits will benefit major 
European crops including wheat, potato, rapeseed and tomato. They will also have benefits in 
crops for both farmers and consumers in developing countries. A striking example is Golden 
Rice, which has been developed over the last decade so that a modest portion of boiled rice 
contains sufficient β-carotene to provide a high proportion of an individual’s daily vitamin A 
requirement. Introduction of Golden Rice could prevent blindness and health problems for 
many poor people who depend on rice-based diets. 
 
In the longer term, transfer of genes for symbiotic nitrogen fixation from legumes to other 
crops, and for more efficient “C4” photosynthesis into “C3” plants such as rice, are likely. 
Once synthetic biology has been developed further, we expect more complex novel traits in 
GM crops including the production of novel compounds for biofuels and industrial use. Such 
GM crops could be key components of an expanding bio-economy. 
 
Safety and risk assessment 
 
Experimentation and commercial release of GM crops in the EU is subject to much more 
stringent regulation than conventionally bred plants, with a slow and inefficient approval 
process. As a consequence, multi-national companies (BASF and Monsanto) have withdrawn 
their research efforts to develop GM crops in Europe, and there has been a significant 
reduction in experimental field trials in the UK, with only one in 2012, compared with 37 in 
1995. As in other countries, in the USA there is a similar stringent regulatory framework, but 
the approval process is more streamlined and effective. As a consequence of the regulatory 
process for commercial release, $7M-14M (2007 prices) is added to the cost of developing a 
new GM crop variety in the U.S.A. – an amount that is prohibitive for small and medium 
sized enterprises. 
 
The European Academies Science Advisory Council (EASAC) and others have pointed out 
that there is no rational basis for the current stringent regulatory process. Stringent regulation 
of the technology would be justified if there were no benefits, if it was associated with 
inherent risks to the health of humans or animals or the environment, and if the technology 
was so poorly understood there was a high probability of unforeseen consequences. However, 
extensive studies over the nineteen years GM crops have been cultivated, have failed to reveal 
any of these risks from transgenes of any type. Notably, even in the highly litigious USA, 
there have been no successful lawsuits, no product recalls, no substantiated ill effects, and no 
other evidence of risk from a GM crop product intended for human consumption since the 
technology was first deployed commercially in 1994. 
 
Conclusions and recommendations 
 
Globally for crop varieties, resistance to pathogens and pests is of high priority (e.g. wheat 
take-all, foliar diseases, barley yellow dwarf virus, aphids, nematodes, slugs), along with 
improvements in genetic yield potential (total biomass production, nutrient use efficiency, and 
climate proofing traits – drought, heat tolerance) and crop quality (starch/oil/protein quality 
and functionality). GM has the potential to contribute substantially to advancing plant 
breeding to deliver these traits in crop varieties, more rapidly and in a more efficient manner; 
and to introduce many novel innovations that cannot be achieved using conventional 
breeding. This will not only help achieve sustainable and sufficient global food production in 
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the face of challenges from a growing population, climate change, and environmental 
degeneration; but also generate a successful bioeconomy (biofuels, fibre and other materials). 
Conventional plant breeding alone is not likely to meet this challenge because the cycle time 
for production of a new crop variety is long (usually a decade) and it is difficult to improve 
multiple crop varieties in the same way. In addition, conventional plant breeding is restricted 
to improvements that can be transferred between related species and it does not have the 
potential to take advantage of innovation in synthetic biology, with assembly of complex 
biosynthetic pathways, to enhance plant performance. To realize the full potential of GM 
crops we need to improve the European regulatory and approval process, and to strengthen 
the R & D pipeline.  
 
Changes to the regulatory and approval process are essential, if GM crops are to be an integral 
component of the agri-tech approaches used by EU farmers to increase crop production, and 
contribute to the bio-economy. As there is no evidence for intrinsic environmental or toxicity 
risks associated with GM crops, it is not appropriate to have a regulatory framework that is 
based on the premise that GM crops are more hazardous than crop varieties produced by 
conventional plant breeding. We therefore endorse EASAC’s proposal that a future regulatory 
framework should be product- rather than process- based. However, even if the safety 
assessment framework were revised, the approval process at the European level for cultivation 
of GM crops in Europe will remain an impediment. For that reason, to safeguard in part 
against the losses and damage to European agriculture that follow from the failure to adopt 
GM crops, we propose that approval for commercial cultivation of new GM crops is made at 
a national level, as happens at present with pharmaceuticals.  
 
Plant breeding is a research-intensive and expensive. A competitive wheat breeding 
programme costs £1M to £1.5M p.a., but is only sufficient for a breeder to make incremental 
advances in crop improvement. Approximately, 30% of the limited breeders’ royalty income 
(less than £20M p.a. for cereals, or £40M p.a. for all broad acre crops in the UK), derived 
from the sale of certified seed and from the use of farm saved seed is spent on R&D. Given 
the limited royalty stream, breeders must breed primarily for mainstream markets, and rely on 
good evidence that laboratory findings will translate into crops in the field. A well-
functioning R&D pipeline is essential for translation of genomic research through the pre-
breeding stage into the development of crop varieties for the marketplace. For these reasons 
we propose the establishment of an R & D programme (PubGM) that would allow evaluation 
of the practical application of academic research findings transferred to crops in the field. This 
would include capacity for field testing new GM crops either in partnership with companies 
or so that the public sector could validate traits before engaging in partnerships with the 
private sector. For crops where there is likely to be little or no market demand but where there 
are environmental or social benefits (for example, minor crops, energy crops, or break crops), 
the public sector is likely to need to undertake the fundamental research, and develop it 
further before it is ready for commercial evaluation. 
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Part 1: Experience of GM crop cultivation 
Summary 
 
 GM crops were first introduced in the USA in 1994 and are now grown in 28 
countries. The acreage under GM cultivation is doubling every 5 years and now 
accounts for some 12% of global arable land. 
 
Most of the present global GM crop acreage is maize, soybean, cotton and 
rapeseed (canola), with the majority (81%) of both soybean and cotton acreage 
sown to GM varieties. However, there are many other commercialised products 
grown on smaller areas. In 2012, biotech crops represented 35% of the global 
commercial seed market. 
 
 Most of the commercially grown GM crops have one or both of two traits – 
glyphosate herbicide resistance and Bt insect resistance. However, a drought 
tolerant maize was recently commercialised in the US and other traits include virus 
resistance in papaya, insect resistance in poplar trees, and flower colour in carnations 
and roses. 
 
 The existing GM crops are popular with farmers because they make it easier to 
control weeds or pests and lead to a reduction in inputs. This can generate 
increased farm income. For example, cumulatively since 1996, GM insect resistant 
varieties have added $25.8 billion to the income of global maize farmers, and 11.6% 
to the global value of the cotton crop. 
 
 GM crops have also resulted in environmental benefits, such as a lower carbon 
footprint, with reduced greenhouse gas emissions, through reduced use of chemicals 
(particularly insecticides) and reduced soil tillage. In addition, there will be less 
damage to non-target organisms compared with the use of chemicals, as GM traits are 
normally specific for the pest or pathogen, whereas crop protection chemicals may 
affect beneficial organisms as well as the intended target. 
 
 It is likely that many more GM crops will be cultivated in the US and other 
countries with permissive regulatory systems. In the USA, between 500 and 1000 
field trial applications are allowed per annum, and the 96 applications for 
commercialisation approved since 1990 are likely to proceed to full commercial 
development. 
 
 Only one GM crop is approved for commercial cultivation in the EU: Bacillus 
thuringiensis (Bt)-insect-resistant maize. The total area of GM maize grown in the EU 
in 2012 was 129,000 hectares; with 90% grown in Spain. 
 
 Whilst less than 0.1% of the global acreage of GM crops is cultivated in Europe, more 
than 70% of EU animal protein feed requirements are imported as GM crop 
products. 
 
 Introduction 
 
In this section, we summarise recent reviews of the status of GM crops in different regions of 
the world. Our aim is to provide a context for the assessment of the future potential for GM 
crops as set out in Section 2 and to describe GM crops grown commercially or in trials and 
close to commercial cultivation.  
A. Agriculture 
GM crops were first introduced in the USA in 1994 (Flavr Savr tomato). In 2012, the 17th 
year of widespread commercialization, and the 15th year of consecutive increase in acreage of 
GM crops grown; a record 170 million hectares were planted in 28 countries. Compared with 
1.7 million hectares sown in 1996, this is a 100-fold increase, making GM crops the fastest 
adopted crop technology in the history of modern agriculture (Figure 1). In 2012, seeds for 
GM crops represented just over a third of global commercial seed sales (James 2012). 
 
 
Figure 1.Global area of GM crops, 1996-2012: industrial and developing countries  
(M Has, M acres). Adapted from: (James 2012). 
 
In 2012, GM crops were grown by a record 17.3 million farmers, of whom over 90%, or over 
15 million, were resource-poor farmers in developing countries. In this year, the growth rate 
for GM crops was higher for developing countries, at 11% or 8.7 million hectares, versus 3% 
or 1.6 million hectares in industrial countries.  
 
The global area of the four major GM crops, soybean, maize (corn), cotton and canola 
(oilseed rape), and their relative adoption rates compared to conventional crop varieties, for 
the period 1996-2011, are shown in Figures 2 and 3 respectively. The adoption rate of GM 
maize is 90% in USA, 65% in Argentina, and 50% (65%) for summer (winter) maize in 
Brazil. GM soybean varieties are now planted for 90- 99% of the crop in the USA, Argentina 
and Brazil; and GM canola now accounts for 98% of the crop in Canada. 
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Figure 2. Global area of GM crops, 1996-2011: by crop (M Has, M acres). Adapted from: 
(James 2012). 
 
 
 
 
Figure 3. Global adoption rates (%) for principal GM crops (M Acres, M Has). Adapted 
from: (James 2012). 
 
The two most important GM traits are herbicide tolerance and insect resistance, and these are 
now increasingly combined in the same product as shown in Figure 4. 
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Figure 4. Global area of GM crops, 1996-2012: by trait (M acres,M Has). Adapted from: 
(James 2012). 
 
Of the 28 countries planting GM crops in 2012, 20 were developing and 8 were industrial 
countries (see Table 2 and Figure 1), with the top five countries (USA, Brazil, Argentina, 
Canada and India) each growing more than ten million hectares (James 2012).  
A1. Socio­economic and environmental impacts 
 
One advantage of the adoption of insect resistant GM crops, has been the decrease in 
environmental impact associated with insecticide use by 18.1% [as measured by the indicator 
the Environmental Impact Quotient (EI Q)]. It has also led to a significant reduction in the 
release of greenhouse gas emissions from the cropping area due to decreased fuel usage. The 
reduction in 2011 was equivalent to removing 10.22 million cars from the roads (Brookes & 
Barfoot 2013b). 
A2. Farm income effects 
 
During the period 1996-2011, the cumulative benefit of GM crops on farm incomes, derived 
from a combination of enhanced productivity and efficiency gains, has amounted to $98.2 
billion, with US $49.6 in developing countries and US $48.6 billion in developed countries. 
Significant gains during this period, have been generated by GM insect resistant (GM IR) 
maize and Bt cotton which have generated an additional US $25.8 billion and US $32.5 
billion for global maize and cotton farmers respectively. 
 
In 2011, the benefit from GM crops of US $19.8 billion, is equivalent to adding 6.3% to the 
value of total global production of soybeans, maize, canola and cotton. The US $7.1 billion 
additional income generated by GM insect resistant (GM IR) maize in 2011 is the equivalent 
of an additional 3.3% to the US $214 billion value of the global maize crop.  
 
Bt cotton has significantly increased the income of farmers, through a combination of higher 
yields and lower costs by halving the number of insecticide sprays. In 2011, gains in farm 
income from GM cotton were US $6.73 billion, equivalent to adding11.6% to the US $56 
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billion value of total global cotton production (Brookes & Barfoot 2013a). Data for Burkino 
Faso are given in Table 1. 
 
Table1. Economic benefit from insect resistant Bt cotton in Burkino Faso. Compiled from 
(James 2012). 
 
Year  Hectares of 
cotton planted 
(total) 
Hectares of Bt 
cotton planted 
% adoption of 
Bt cotton 
National benefit 
from Bt cotton in 
million US$ 
2008  475000 8500 2% no data available 
2009  400000 123000 29% 35 
2010  400000 260000 65% 80 
2011  424810 247000 58% 70 
 
 
 
Table 2. Global area of GM crops in 2012: by country (M Has). Source: (James 2012). 
___________________________________________________________________________
Rank  Country Area (M Has)  Crops 
1  USA  69.5   Maize, soybean, cotton, canola,  
       sugarbeet, alfalfa, papaya, squash 
2  Brazil  36.6   Soybean, maize, cotton 
3  Argentina 23.9   Soybean, maize, cotton 
4  Canada 11.6   Canola, maize, soybean, sugarbeet  
5  India  10.8   Cotton 
6  China  4.0   Cotton, papaya, poplar, tomato, sweet 
 pepper 
7  Paraguay 3.4   Soybean. maize, cotton 
8  South Africa 2.9   Maize, soybean, cotton 
9  Pakistan 2.8   Cotton 
10  Uruguay 1.4   Soybean, maize 
11  Bolivia 1.0   Soybean 
12  Philippines 0.8   Maize 
13  Australia 0.7   Cotton, canola 
15  Burkina Faso 0.3   Cotton 
14  Myanmar 0.3   Cotton 
16  Mexico 0.2   Cotton, soybean 
17  Spain  0.1   Maize 
19  Chile  <0.1   Maize, soybean, canola 
18  Colombia <0.1   Cotton 
20  Honduras <0.1   Maize 
21  Sudan  <0.1   Cotton 
22  Portugal <0.1   Maize 
23  Czech Rep. <0.1   Maize 
24  Cuba  <0.1   Maize 
25  Egypt  <0.1   Maize 
26  Costa Rica <0.1   Cotton, soybean 
27  Romania <0.1   Maize 
28  Slovakia <0.1   Maize 
Total    160.0 
 
 A3. Commercial GM cultivation in the EU 
 
In the EU, only two GM crops are approved for commercial cultivation: Bacillus 
thuringiensis (Bt)-insect-resistant maize and a potato variety with modified starch 
composition for industrial use (now withdrawn). In 2012, the total area of GM maize grown 
in the EU amounted to 129,000 hectares, with 90% of this total grown in Spain (EASAC 
2013) (Figure 5). However, each year the EU imports more than 70% of its animal protein 
feed requirements for livestock as feed derived from GM crops (mostly soybean). This 
approximates to 20 million metric tonnes grown on 7 million hectares of agricultural area 
(EASAC 2013). 
 
 
 
Figure 5. Area of GM maize grown in Europe 2003-2013. (USDA, 2013). 
A4. GM crop regulation in the USA 
The USA uniquely operates deregulation, allowing applications to request that a specific GM 
product is equivalent to the non-GM version and therefore should no longer be regulated and 
therefore not labelled. All GM crops on the USA market currently have achieved a 
deregulated status. There have been 96 approvals for deregulation since 1990; these comprise 
examples from alfalfa, canola, corn, cotton, flax, rose, papaya, plum, potato, rice, soybean, 
squash, sugar beet, tobacco, and tomato. Those not already on the market, are likely to 
proceed to full commercial development. There are also 13 applications pending decision 
which represent the next group of GM crop varieties available on the market; these include 
alfalfa (1), apple (1) (non-browning), corn (1), cotton (1), creeping bentgrass (1), eucalyptus 
(1) (cold tolerance), potato (1), and soybean (6) (Information Systems for Biotechnology 
2013a). The most recently deregulated products are glyphosate tolerant canola (oil seed rape) 
(Pioneer/Monsanto), glyphosate tolerant corn and a novel F1 hybrid seed production system 
for corn (Monsanto) (USDA, 2014). 
The numbers of US GM field trial applications are shown by year of application, crop and 
GM trait in Figures 6, 7 and 8 respectively. Each of these applications may cover a range of 
GM lines of a particular crop grown in one or more locations, and all commercial products 
will have been tested under this system over a period of several years and at several locations. 
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In 2013, there were 601 trials, with herbicide tolerant corn representing the largest category 
(Figures 7 and 8). 
 
 
Figure 6. Number of US field trial 
applications by year 1985-2014. Data for 
Figures 6-8 from (Information Systems for 
Biotechnology 2013b) 
Figure 7. Numbers of field trial permits 
by crop. 
 
Figure 8. US field trial permits by trait. 
 
 
 
 
 
A5. GM crop field trials in the EU and elsewhere 
Applications for GM field trials in the EU during 2013 (European Comission Joint Research 
Centre 2013) included those from Spain, Poland, UK, Finland, Belgium, Sweden, Slovakia, 
Romania, France, and refer to trials of maize, wheat, poplar, sugar beet, cotton, and 
cucumber. Although commercial GM crops are grown in only four African countries - 
Burkina Faso, Sudan, South Africa and Egypt (Table 2) several more countries are now 
conducting field trials or are due to do so (FARA 2013) (Figures 9 and 10). For example, in 
2013 Ghana granted permission for trials of GM rice, sweet potato, cotton and cowpea 
(Quandzie 2013) and Malawi established its first trial of GM cotton (NEPAD 2013).  
  
 
Figure 9. Summary of Confined Field Trials (CFT) of GM crops in Africa. (Data taken 
from (Savadogo 2010)). 
 
 
Figure 10. Status of GM Crops in Africa showing Confined Field Trials (CFT) and 
presence of biosafety laws (ABNE 2013).
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 B. Horticulture 
B1. Papaya 
 
GM papaya with resistance to papaya ringspot virus (PRSV) was not only the first GM tree 
and fruit crop, but also the first transgenic crop developed by a public institution to be 
commercialized (1998). It is also the first commercial GM product approved for direct 
consumption in Japan (Dec 2011) and China (Dangl et al. 2013). 
B2. Other commercialized horticultural products 
 
 
(Copyright Clearance Centre RightsLink® License Number 3336440386502) 
 
Figure 11. Colour modification in Dianthus caryophyllus (carnation). Flowers are shown 
from a control plant (right) and from a transgenic plant (left) expressing the flavonoid 
3′5′-hydroxylase gene from Viola tricolor (pansy). (Chandler & Sanchez 2012).  
 
Commercial GM flowers include one rose variety (R. hybrida) and eight varieties of 
carnations (D. caryophyllus) developed by Florigene Pty.Ltd. / Suntory Ltd (Florigene 
Flowers 2013) with modified flower colour generated by manipulation of the anthocyanin 
biosynthetic pathway. In nature, carnations and roses do not contain delphinidin derived 
anthocyanins, due to the absence of flavonoid 3’5’-hydroxylase. Introduction of this gene 
from Petunia hybrida (petunia) or Viola tricolor (pansy), in conjunction with other 
modifications to the endogenous anthocyanin biosynthesis pathway (to minimize substrate 
competition) results in an accumulation of delphinidin-related anthocyanins in flowers, 
conferring a unique colour (Figure 11). GM carnations were first marketed in Australia in 
1997 and are now grown commercially in South America, Australia and Japan. Cut flowers 
are exported for sale primarily in North America, but also in Europe and Japan (Chandler & 
Sanchez 2012).  
C. Forestry 
 
The only known commercial-scale cultivation of a GM forest tree species is in China where 
two varieties of insect-resistant poplars have been planted since 2002 and by 2011 occupied a 
total of 490 ha, with one variety planted at eight sites in seven provinces (Häggman et al. 
2013). One variety is Populus nigra transformed with the cry1Ac gene from Bacillus 
thuringiensis (Bt) and the second variety is a hybrid white poplar which is transformed with a 
fusion of cry1Ac and API (a gene coding for a proteinase inhibitor from Sagittaria 
sagittifolia). The transgenic P. nigra has also been hybridized with non-transgenic Populus 
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deltoides to generate insect-resistant germplasm for a breeding programme designed to 
generate new hybrid varieties, that could expand the planting area of Bt poplar (Häggman et 
al. 2013). 
 
A summary of confined field trial data for GM forest tree species in various countries is given 
in Table 3. These include tests of a GM Eucalyptus variety with improved cold tolerance 
(Häggman et al. 2013) and designed for biofuel use (ArborGen 2013). Also of interest is the 
US trial of GM chestnut expressing an oxalate oxidase gene that provides resistance to 
chestnut blight (Cryphonectria parasitica) (B. Zhang et al. 2013), one of a number of fungal 
pathogens that represent an increasing threat to UK forestry. 
 
Table 3. Summary of confined field trials approved for genetic engineering forest trees 
in different countries 
___________________________________________________________________________ 
Country or Species and    Source 
Region  no. trials     
___________________________________________________________________________ 
USA  Populus spp. (212), Pinus spp. (154)   http://www.aphis.usda.gov/brs/status 
  Eucalyptus spp. (77),   /BRS_public_data_file.xlsx 
  Liquidambar styraciflua (37), 
  Castanea dentata (15), 
  Ulmus americana (5), 
  Picea glauca (1) 
China  Populus spp. (34),   M.-Z. Lu, Chinese Academy of Forestry, 
  Robinia pseudoacacia (25),  (pers. comm..) 
  Larix spp. (16), Paulownia (3) 
Brazil  Eucalyptus (65)    http://www.ctnbio.gov.br/index.php/  
content/view/3509.html 
Canada  Populus (28), Picea mariana (10), http://www.inspection.gc.ca/english/ 
  P. glauca (7)    plaveg/bio/confine.shtml#sum 
EU  Populus spp. (30), Betula pendula (6), http://gmoinfo.jrc.ec.europa.eu 
  Eucalyptus spp. (4), Picea abies (2), /gmp_browse.aspx, 
  Pinus sylvestris (2)   http://gmoinfo.jrc.ec.europa.eu/overview/ 
Japan  Eucalyptus (7), Populus (2)  http://www.bch.biodic.go.jp/english 
       /e_index.html 
New  Pinus radiata (5)   http://www.epa.govt.nz/new-organisms 
Zealand      /popular-no-topics/Pages/GM-field-tests- 
       in-NZ.aspx 
Australia N/A     http://www.ogtr.gov.au/internet 
       /ogtr/publishing.nsf/Content/ir-1 
Taken from: (Häggman et al. 2013). (CC-BY-3.0)
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Part 2: New scientific developments over the last 5 years 
 
Summary 
 
 Recent laboratory science has identified genes with effects in experimental 
situations that could benefit crop plants including: photosynthetic efficiency, 
nitrogen use efficiency, aluminium tolerance, salinity tolerance and other abiotic 
stresses, pest and disease resistance, and phosphate use efficiency. In the longer term, 
nitrogen fixation in GM crops is likely, and once synthetic biology has been 
developed, there is the potential for developing more complex novel traits in plants, 
including the production of novel compounds for biofuels or industrial biotechnology. 
 
 GM traits developed for specific use in major European crops including wheat, 
potato, rapeseed and tomato to benefit crop production or product quality for food or 
biofuel use are available, if they could be introduced under a permissive regulatory 
and approval system. 
 
 GM traits specifically for developing countries include nutritional enhancement 
(golden rice and others), as well as pest and disease resistance for tropical diseases. 
 
 The potential for more traits in GM crops is likely to increase greatly through the 
availability of high throughput genome sequencing with access to genes from 
plant and microbial sources.  
 
 New technologies for targeted gene modification will also greatly enhance the 
potential of GM crops.  
 
Introduction 
 
In this section we describe GM crops that could be commercialised in the short and medium 
term. The short-term examples involve either traits that have been validated by testing in 
model species or crops in the laboratory. The longer-term prospects will follow from current 
research that is identifying the genes that are responsible for important traits. The potential of 
GM crops is also influenced by technological advances. Progressive innovation in sequencing 
technology, for example, means that it is now much easier than ever before to identify genes 
and sets of genes affecting the traits of crop plants. Other innovations will allow genetic 
modification of crop plant genomes to be targeted to specific genomic locations. Current 
technologies, by contrast, are untargeted. The gene targeting or “genome-editing” 
technologies are important for two reasons. First, they will increase the range of genetic 
modifications that can be introduced in crop plants. Second, they blur the distinction between 
GM and non-GM: the end result of a gene targeted modification might be indistinguishable 
from a non-GM variety created by chemical or radiation mutagenesis. 
 
Section A focuses on traits, whereas Section B focuses on the crops where these traits would 
be useful for Europe. Section C explores which traits would be useful in crops for developing 
countries; and Section D considers the recent developments in techniques and methods which 
will expand the list of available traits to those involving multiple genes. 
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A. GM traits “in the pipeline” to benefit many crops 
 
Although there are relatively few types of first generation transgenes cultivated in the field 
(Section 1), there are many examples of traits “in the pipeline” that have been developed in 
the laboratory and that could be assessed in the field if the regulatory framework were not so 
restrictive. These second generation GM traits differ from the first generation in that they are 
more likely to involve genes from plants rather that microbes and they may involve multiple 
genes to confer a single trait. Scores, if not hundreds, of potentially useful genes have been 
added to plants using GM methods. For reasons of commercial secrecy, not all are in the 
public domain. Some are in advanced stages of trials in the private sector, primarily for the 
US market (CropLife International 2013). A selection of emergent and imminent second 
generation GM traits are described below. 
A1. Enhanced photosynthesis 
 
There is scope for enhancing the efficiency of photosynthesis, the remarkable process by 
which plants use light energy from the sun to convert carbon dioxide (CO2) into sugars that 
can be used for plant growth. A process called photorespiration reduces this efficiency, and 
delivery of five bacterial genes greatly reduces losses to photorespiration and increases yield 
(Kebeish et al. 2007). Elevated levels of sedoheptulose bisphosphatase (one of the carbon 
fixation pathway enzymes), also increases photosynthetic efficiency and thus yields 
(Rosenthal et al. 2011).  
 
Longer term innovations include exploitation of a carbon-concentrating mechanism that 
improves the photosynthetic efficiency of certain algae (Meyer et al. 2012). Finally, many 
laboratories are also seeking to bring the efficient C4 photosynthetic system from plants such 
as maize, to wheat, rice and other plants that carry a less efficient C3 photosynthetic system 
(Leegood 2013; Slewinski 2013). This is a more challenging, long-term, high-risk-high-
reward goal, being addressed by an international consortium funded by the Gates Foundation 
(IRRI 2013). 
A2. Stress tolerance 
 
Plants are exposed to extreme variation in light intensity, temperature and water availability, 
and these stresses can impinge on the efficiency of photosynthesis and thus yields. Water 
stress can result in a state called “photo-oxidative stress”, where the stomata close to avoid 
loss of water, and CO2 levels in the leaf drop, and although the plants have plenty of energy 
for photosynthesis this cannot be used to fix CO2, and causes damage to the plant. Several 
GM traits appear to increase yields by alleviating this damage. For example, an algal 
flavodoxin appears to rescue the damage caused to plant ferredoxin during this kind of stress 
(Zurbriggen et al. 2008).  
 
Monsanto are most advanced with GM approaches to water stress tolerance, using a bacterial 
RNA chaperone protein (Castiglioni et al. 2008); and have recently commercialised a 
drought-resistant maize in the US. Drought tolerant transgenes are being made available by 
Monsanto through a public private partnership to improve maize varieties for African farmers 
(see Box 1). Several groups are engineering plant regulators called transcription factors to 
elevate plant stress tolerance, although it is not clear how close these are to commercialization 
(Nelson et al. 2007). Arcadia have also adopted a drought tolerance technology (pSARK:IPT) 
that also appears to show good promise (Peleg & Blumwald 2011). 
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Box 1 - Water Efficient Maize for Africa 
 
The WEMA programme led by the African Agriculture Technology Fund (AATF) with joint 
funding from the Bill and Melinda Gates Foundation, and the Howard G. Buffett Foundation, 
is developing heat and drought tolerant maize varieties to help more than 300 million Africans 
depending on maize as their main food source. Monsanto will provide proprietary germplasm, 
advanced breeding tools and expertise, and drought-tolerance transgenes developed in 
collaboration with BASF. The International Maize and Wheat Improvement Center 
(CIMMYT) will provide high-yielding maize varieties adapted to African conditions and 
expertise in conventional breeding and testing for drought tolerance. AATF will distribute the 
varieties to African seed companies without royalty so they can be made available to 
smallholder farmers. The national agricultural research systems, farmers’ groups, and seed 
companies taking part in the programme will contribute their expertise in field testing, seed 
multiplication, and distribution. National authorities will assess the benefits and safety of the 
varieties according to regulatory requirements in the partner countries: Kenya, Mozambique, 
South Africa, Tanzania and Uganda. 
A3. Aluminium tolerance 
 
Acid soils comprise 30% of the Earth’s ice-free land. At soil pH values above 5, aluminium 
exists in the soil in non-toxic forms. However, when soils are acidic, Al3+ ions are freed in the 
soil, and damage the root tips of susceptible plants, inhibiting root growth, and impairing the 
uptake of water and nutrients. A naturally occurring tolerance mechanism of several species 
to aluminium toxicity in soils, is the transport of organic anions, by proteins, from inside root 
cells to the external medium surrounding roots, where they chelate Al3+ into a non-toxic form, 
allowing the roots to grow unimpeded. The wheat TaALMT1 gene facilitates malate efflux 
from roots to elevate Al3+ tolerance, and can be used to genetically modify susceptible species 
for improved Al3+ tolerance. When expressed in barley, one of the most Al3+ sensitive cereal 
crops, TaALMT1 confers substantially improved grain yields in acid soil.  
 
Engineering plants to overexpress citrate also elevates Al3+ tolerance(de la Fuente et al. 1997). 
In sorghum, barley, and maize, plant multidrug and toxic compound extrusion (MATE) 
transporters located at the root tip confer Al3+ activated citrate efflux and represent the 
primary Al3+ tolerance proteins. These proteins are also promising for GM approaches to 
elevating Al3+ tolerance (Schroeder et al. 2013). 
A4. Salinity 
 
Production in over 30% of irrigated crops and 7% of dryland agriculture worldwide is limited 
by salinity stress. Crop irrigation is increasing soil salinity, owing to trace amounts of salt in 
irrigation waters. Research in the reference plant Arabidopsis and rice has shown that the 
‘class 1’ HKT plant plasma membrane transporters are sodium (Na+) selective and protect 
plant leaves from salinity stress by prohibiting toxic over-accumulation of Na+ in the 
photosynthetic leaf tissue, through removal of excess Na+ in the xylem vessels that carry 
nutrients and water to the leaves. Analogous mechanisms have been demonstrated in wheat 
for the HKT1;4 and HKT1;5 genes. The recent introgression of an ancestral form of the 
HKT1;5 gene from the more Na+-tolerant wheat relative Triticum monococcum into a 
commercial durum wheat species which is susceptible to salinity, (Triticum turgidum ssp 
durum) has increased grain yields on saline soil by 25% (Schroeder et al. 2013). 
 
Class 2 HKT transporters which mediate cation influx into the roots, together with 
transporters that sequester sodium and potassium in the vacuole (class 1 Na/H antiporters), 
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could improve the production of cereals such as barley which copes with high Na+ loads in 
leaves by compartmentation in the vacuole. Combining HKT transporter traits with vacuolar 
Na+ sequestration mechanisms provides a potentially powerful approach to improve the 
salinity tolerance of crops (Schroeder et al. 2013). In the short and medium term, as genes are 
identified that confer these traits, their introduction by GM methods, alone or in combination, 
should elevate salinity tolerance in other crop species.  
A5. Pest and disease resistance 
 
Infectious disease is one of the biggest threats to crop production in all environments (Oerke, 
2005). Of the available control methods, genetically resistant crop varieties are the most 
preferable, as they do not damage non-target organisms, reduce exposure of farm workers to 
chemicals, and do not incur CO2 emissions from applications of chemicals by tractors.  
 
The available strategies for GM disease resistance can be considered as either artificial or 
based on natural mechanisms.  
 
Artificial approaches include:  
 
1) Bt traits (referred to in Section 1) in which a bacterial gene conferring resistance to some 
insect pests is transferred into the crop variety. 
 
2) Interfering RNA (RNAi) technology, which exploits an RNA silencing mechanism with 
small RNA (sRNA) molecules blocking the activity of RNA molecules that are 
complementary to the sRNA. The first examples of RNA silencing mediated resistance 
have been the design of transgenes to target a viral gene that is essential for the viral life 
cycle, enabling plants to be highly resistant to the virus disease. A recent example of such 
a trait provides resistance in Pinto beans to bean golden mosaic virus (Bonfim et al. 2007) 
with the potential to increase production by 10-20%, and was approved in 2011 by the 
Brazilian National Technical Commission on Biosafety (CTNBio) (Tollefson, J., 2011). 
The silencing RNAs are incredibly mobile, moving not only between cells of the plant but 
also from a plant to an invertebrate pest or into a fungal pathogen. Transgenic plants 
producing sRNA targeted to an essential gene of a pest or pathogen can, therefore, be 
resistant against this pest (e.g. cotton bollworm) (Mao et al. 2007). As a safeguard the 
transgene is designed so that the sRNA would have no effect on mammals. RNAi against 
a corn rootworm transporter gene Snf7 is currently in the Monsanto pipeline with 
commercial production expected by the end of this decade. 
 
3) Engineering a metabolic pathway as in wheat to produce β-farnesene, an insect alarm 
pheromone, making wheat plants resistant to colonization by aphids has been carried out 
by Rothamsted Research in the UK (Beale et al. 2006). 
 
Natural mechanisms involve taking genes involved in natural disease resistance and 
transferring them as transgenes into disease-susceptible varieties (Dangl et al. 2013).  
A6. Nitrogen use efficiency 
 
Technologies developed by Arcadia (Arcadia Biosciencs 2013) for nitrogen use efficiency 
based on alanine aminotransferase, enhance absorption of nitrogen by crops so that lower 
levels of N fertilizer can be applied without compromising yield (McAllister et al. 2012). 
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A7. Phosphate use efficiency 
 
Phosphorus (P) is a macro-element that is essential for plant growth and crop yield. The 
availability of inorganic P, or orthophosphate (the only form of P directly accessible to 
plants), is influenced by soil chemistry and limits crop production on most soils. 
Consequently, crop production depends on orthophosphate fertilizers, produced from rock 
phosphate, a finite, non- renewable mineral resource. Only 20–30% of the P fertilizer applied 
is absorbed by cultivated plants and at the current rate of use. It is estimated that rock 
phosphate reserves will be consumed within the next 70–200 years, so sustainable use of 
orthophosphate is important. Improving orthophosphate acquisition and use-efficiency in 
plants is a complex problem and recent solutions have included modifications to root growth 
and architecture, and novel engineering strategies to use alternative sources of P. Plants 
possess several families of orthophosphate transporter proteins, with both high- and low-
affinity phosphate transporters, important for orthophosphate uptake into roots, and also 
critical for orthophosphate distribution throughout the plant, and for remobilization between 
source and sink tissues. The rice Pstol1 gene confers tolerance of phosphorus deficiency, and 
would be expected to confer this trait if moved to other species by GM methods (Gamuyao et 
al. 2012). 
 
Plants cannot utilize phosphite as a P source, but GM plants carrying a bacterial phosphite-
utilization gene PtxD enables reduction in the level of P application required for full growth, 
and with phosphite as sole source of P, enables effective selection against weeds, and offers a 
potential control method for blackgrass (see next section) (López-Arredondo & Herrera-
Estrella 2012).  
 
Seeds store phosphate in the form of inositol 6 phosphate (phytic acid). When eaten by 
domestic animals such as pigs and chickens, phytic acid passes through the gut unprocessed 
and the resulting PO4-rich effluent promotes water eutrophication. China has approved 
deployment of a maize variety that expresses the enzyme phytase in maize seed, breaking 
down phytic acid by hydrolysis during digestion, and making phosphorus available to the 
animal, which on excretion does not pollute watercourses (Bohn et al. 2008). 
A8. Nitrogen fixation 
 
Nitrogen fertilizer is produced via the energy-intensive Haber-Bosch process that combines 
hydrogen and nitrogen to make ammonia. For farmers in Africa, synthetic fertilizer is much 
more expensive than for farmers in the US, largely because of transportation costs and 
economies of scale. Some plants recruit nitrogen-fixing bacteria into specialized structures- 
“nodules”- within which, in return for plant-derived sugars, bacteria supply the plant with 
biologically fixed nitrogen-containing compounds. If crops like wheat, maize and sorghum 
could be modified to accommodate these nitrogen-fixing bacteria, yields of these staple grains 
in Africa could be significantly elevated. However, the process of nodule development in 
response to these bacteria is complex and involves many plant genes. The target of nitrogen 
fixing cereals is another long-term and high-reward programme funded by the Gates 
Foundation (ENSA 2013). 
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B. GM traits for European crops 
 
This section outlines which European crops could benefit from GM technology and which 
traits would be most useful. Table 4 gives an overview. 
B1. Wheat 
 
In the UK, 20,000 farms in England are sprayed against black-grass (on at least one field) and 
the total area sprayed with grass-weed herbicides is about 1 million ha. A herbicide-resistant 
wheat, would be very useful. Alternatively, the phosphite utilization trait conferred by PtxD 
(see above) could favour the crop against weeds. Both these traits could be developed in the 
short/medium term. 
 
A major disease of wheat is “take-all”. Oats are resistant to wheat strains of the disease, 
because unlike wheat, they make avenacin, an antibiotic. The oat genes for avenacin 
biosynthesis are close to being fully characterized (Qi et al. 2004; Geisler et al. 2013); and 
work is well advanced by the John Innes Centre in the UK to move these genes into wheat 
varieties for take-all control in the short/medium term. 
 
There is scope for nutritional enhancement of wheat. Coeliac disease in humans results from 
an allergic response to certain wheat proteins. Lines of wheat have been generated using 
RNAi, to eliminate these proteins without reducing bread-making quality or animal feed 
utility of the grain(Gil-Humanes et al. 2010; van den Broeck et al. 2009). Compared with 
wheat, oats have a lower glycaemic index (GI) for the same amount of carbohydrate, due to 
elevated levels of a CSLH gene promoting (1,3;1,4)-β-D-glucan accumulation (Burton et al. 
2006; Burton et al. 2011). Low GI foods release sugar more slowly, whereas a diet rich in 
high GI foods is associated with larger pulses of sugar that may promote type II diabetes. 
Compared to starch, (1,3;1,4)-β-D-glucan is digested more slowly, with the help of specific 
human gut microflora (Brennan & Cleary 2005). If one were to express this class of CSLH 
gene in wheat, potatoes and tomatoes, the resulting product would be expected to promote 
healthier diets and lower GI food. 
 
Worldwide losses to wheat rusts are substantial. Programmes are underway in the UK and 
elsewhere to clone multiple genes for wheat rust resistance from wild or cultivated relatives of 
wheat, and to “stack” multiple different rust resistance genes on the same transferred DNA 
(T-DNA) to confer disease resistance (Periyannan et al. 2013; Saintenac & Zhang 2013; Two 
Blades Foundation 2013).  
B2. Potato (and apple) 
 
Potato late blight was the biotic cause of the Irish potato famine and is still the major 
worldwide disease of potato. The disease organism (Phytophthora infestans) evolves rapidly, 
but several research groups, including the Sainsbury Lab Norwich, are isolating multiple new 
resistance genes against this disease. Multiple resistance genes can now be delivered on the 
same T-DNA (“stacking”), which will make it more difficult for the pathogen to overcome 
such genetic resistance. An early example of a potato variety produced using this approach is 
Fortuna, which carries two resistance genes (Rpi-blb1 and Rpi-blb2) but was withdrawn by 
BASF as a result of the hostile EU market conditions. In 2010, Amflora was authorised for 
cultivation and industrial processing in the EU however, for strategic/marketing reasons 
BASF withdrew it from commercial sale and it has no longer been cultivated in the EU since 
2011. In 2013, a case was taken to the EU court claiming that the EC had not followed its 
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own guidelines, and won. The EC annulled the authorisation in Dec 2013 (General Court of 
the European Union, 2013). This provides one of the most conspicuous examples of the 
impact the European regulatory regime has in deterring deployment of improved GM crops in 
Europe (BASF 2012; Turley 2013). 
When potatoes are processed into French fries or potato crisps, chemical reactions occur 
during cooking between the natural amino acid, asparagine and naturally present or added 
reducing sugars, resulting in the formation of acrylamide which is considered to be a 
genotoxic carcinogen (Joint FAO/WHO Expert Committee on Food Additives 2005). Absent 
in raw food, or the raw materials used to make food, acrylamide is a chemical substance 
produced naturally when processed foods are subjected to temperatures greater than 120ºC 
during manufacture. An American company, Simplot, has initiated regulatory approval for 
potato varieties in which GM has been used to reduce levels of genes that result in high 
arginine and reducing sugar levels, and also reduced the tendency for bruising via silencing of 
polyphenol oxidase (PPO). This trait would also be likely to benefit European consumers. 
Potato is also susceptible in warmer, wetter conditions to bacterial wilt caused by Ralstonia 
sp. A bacterial resistance gene, EFR, from the plant Arabidopsis, introduced into tomato by 
GM, confers enhanced resistance to this disease and is expected to work the same way in 
potato(Lacombe et al. 2010). There are also credible GM solutions to potato cyst nematode 
(eelworm), an extremely important constraint on yield, and to several potato viruses. 
 
Bruising in apples, as in potatoes, results in browning, and requires the activity of polyphenol 
oxidases (PPOs). A Canadian company, Okanagan Speciality Fruits, is seeking to 
commercialize an engineered apple in which RNAi suppresses the PPO genes, resulting in 
reduced browning once it has been cut/sliced, thereby prolonging shelf life and reducing 
waste (Arctic Apples 2013). 
B3. Rapeseed (Brassica napus) and other oilseeds 
 
Plant oils lack the health-beneficial omega-3 long chain polyunsaturated fatty acids (LC-
PUFAs) which are found in fish oils and those from other marine organisms such as algae and 
krill. There has been considerable interest and effort in developing oilseed crops in which the 
omega-3 LC-PUFAs such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) 
are produced. Such fatty acids can reduce the risk of cardiovascular disease (Flock et al. 
2013) but natural stocks from the oceans are a diminishing resource.  GM oilseed crops such 
as Brassica napus and Camelina sativa have been developed to accumulate EPA and DHA in 
their seed oils, representing a potential sustainable, terrestrial source of fish oils.   
B4. Tomato 
 
Tomato is subject to many diseases and with the limited diversity in germplasm available for 
breeding, resistance for some of these, is best introduced by GM methods. The Arabidopsis 
EFR gene confers Ralstonia resistance to tomato as well as potato (Lacombe et al. 2010). 
 
GM tomatoes developed at the John Innes Centre in the UK, have elevated levels of health-
promoting flavonols and flavonoids in the fruit, and the juice has been shown to extend the 
life of cancer-prone mice by 30% (Butelli et al. 2008). These lines also show an extended 
shelf life, which could reduce post-harvest losses, and allow harvesting after more flavour has 
developed (Y. Zhang et al. 2013). This potentially valuable technology is being 
commercialized in North America, long before it is commercialized in Europe. 
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Table 4. GM traits for European crops 
 
Species  Problem   Potential solution /  
desirable traits 
Progress  Publications 
Take-all disease 
which is a fungal 
rot 
Oat genes for avenacin 
biosynthesis which 
make oat resistant to 
wheat strains of take-
all. 
Oat genes for 
avenacin biosynthesis 
are nearly fully 
characterised at JIC. 
(Papadopoulou et al. 
1999; Mylona et al. 
2008) 
Wheat rust Clone and transfer 
multiple wheat rust 
resistance genes from 
wild and cultivated 
wheat relatives 
  
Blackgrass 
infestation of 
wheat and barley 
fields can 
significantly 
reduce the yield 
Glufosinate resistant 
wheat as farmers use 
glyphosate to get rid of 
weed wheat. 
Implementable 
immediately. 
 
Wheat  
(Triticum 
aestivum) 
 Hybrid seed 
production: Transgenic 
methods for hybrid 
wheat seed production 
could lead to yield 
increases of up to 10% 
  
 Cereal aphids 
causing direct 
feeding damage 
and transmission 
of barley yellow 
dwarf virus 
Engineer wheat to 
produce the aphid 
alarm pheromone to 
repel aphids and attract 
beneficial organisms 
such as aphid 
parasitoids. 
The elite wheat 
variety Cadenza has 
been engineered 
accordingly and 
works well against 
aphids in the 
laboratory and 
increases parasitoid 
foraging. Confined 
field trials are in 
progress at 
Rothamsted Research. 
(Beale et al. 2006) in 
model crop 
Arabidopsis thaliana. 
No publications on 
confined field wheat 
trials until complete 
Potato late blight 
(caused by 
Phytophtora 
infestans the 
causal agent of the 
Irish potato 
famine) 
Multiple new resistance 
genes from wild potato 
species are being 
isolated and by 
introducing multiple 
genes, in a single event, 
into the potato it will 
be harder for the 
pathogen to overcome 
this resistance. 
Several labs in the 
UK and elsewhere are 
isolating new 
resistance genes 
Field trials in 
Norwich. 
(Tan et al. 2010; 
Foster et al. 2009) 
 
Acrylamide 
formation during 
frying of potatoes 
GM potato varieties 
with reduced levels of 
arginine and reducing 
sugar which are the 
cause of acrylamide 
formation. 
Regulatory approval 
initiated by American 
company Simplot. 
http://www.simplotpl
antsciences.com/  
Potato 
(Solanum 
tuberosum) 
Bruising of 
potatoes and 
apples result in 
browning and a 
loss of commercial 
value 
Silencing of 
polyphenol oxidase 
(PPO). 
Regulatory approval 
initiated by American 
company Simplot. 
A Canadian company 
is trying to 
commercialise an 
apple with suppressed 
PPO. 
 
http://www.simplotpl
antsciences.com/  
http://www.arcticappl
es.com/  
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Bacterial wilt 
caused by 
Ralstonia bacteria 
A bacterial resistance 
gene, EFR, from 
Arabidopsis has been 
introduced into tomato 
and confers enhanced 
resistance. Expected to 
work the same way in 
potato and bananas. 
Analysed under 
controlled laboratory 
conditions. 
(Lacombe et al. 
2010) 
Potato Cyst 
nematode 
(eelworm) feed on 
and infest potato 
roots and can lead 
to significant yield 
losses. 
Potato cyst nematodes 
are difficult to fight 
naturally although 
some cultivars show 
some resistance. If this 
resistance is combined 
with an expression of 
cystatin in the roots, 
good resistance can be 
achieved. Cystatin is a 
plant protein found for 
example in rice that 
interferes with feeding 
behaviour in 
nematodes. Further 
studies have 
investigated a peptide 
that interferes with the 
chemoreception of the 
nematodes. 
Field trials for both 
the cystatin and the 
peptide have been 
conducted and shown 
that they lead to good 
resistance without 
impacting on soil 
quality. 
(Green et al. 2012; 
Urwin et al. 2003; 
Lilley et al. 2004) 
Bacterial wilt 
caused by 
Ralstonia bacteria 
A bacterial resistance 
gene, EFR, from 
Arabidopsis has been 
introduced into tomato 
and confers enhanced 
resistance. 
Analysed under 
controlled laboratory 
conditions. 
(Lacombe et al. 
2010) 
Tomato 
(Solanum 
lycopersicu
m) 
 Concentrations of 
health promoting 
flavonols and 
flavonoids have been 
increased in tomatoes 
by a group at JIC and it 
has been shown that 
juice from these 
tomatoes extends the 
life span of cancer-
prone mice by 30%. An 
increase in anthocyanin 
production also 
increases the shelf-life 
of the fruits. 
Grown in the 
greenhouse. 
Commercial field 
trials in the USA. 
(Butelli et al. 2008; 
Y. Zhang et al. 2013) 
 
Oilseed rape 
(Brassica 
napus) 
And 
Camelina 
(Camelina 
sativa) 
 Oilseed crops are being 
developed to 
accumulate omega-3-
LC-PUFAs such as 
EPA and DHA, 
representing a potential 
sustainable, terrestrial 
source of fish oils. 
Such fatty acids can 
reduce the risk of 
cardiovascular disease.  
Could be available 
within a decade. 
 
(Flock et al. 2013) 
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B5. Bio­fuels and industrial biotechnology 
 
Plants can provide a renewable alternative to fossil fuels, as feedstocks for biofuels e.g. sugar 
(sugar beet, sugar cane), starch (corn, wheat), oil (rape seed) and woody ligno-cellulose 
(willow). 
 
In Brazil, sugarcane is an important source of bioethanol production. Sugarcane productivity 
can be limited by availability of “sinks” to receive sugars resulting from photosynthesis. GM 
sugarcane that expresses a vacuole sucrose isomerase, can increase photosynthetic rates by 
diverting sugars into the high value sugar isomaltulose and preventing photosynthesis 
“backing up” (Wu & Birch 2007). Sugarcane production is constrained by water and mineral 
availability, and by pests and diseases, so in principle many of the technologies explored in 
this section could be applied to sugarcane, although currently such deployment is not 
imminent. 
 
To date, the only commercialised GM cereal with a biofuel-related trait is Enogen™, a maize 
hybrid developed by Syngenta (Syngenta 2012), expressing a thermostable alpha amylase for 
efficient starch hydrolysis and higher bioethanol yields. Ethanol throughput during 
fermentation is increased by 5.2% and the financial benefit is between 8-15 US cents per 
gallon. 
 
Various approaches are being taken to improve the efficiency of biofuel production (Zhang 
2013). These include the production of bacterial amylopullulanase in maize grain (Nahampun 
et al. 2013), thermostable xylanases in maize stover (Shen et al. 2012); glycoside hydrolases 
(Brunecky et al. 2012) and an Acidothermus cellulolyticus endoglucanase in transgenic rice 
seeds (Q. Zhang et al. 2012). Additionally, decreasing expression of the regulation of the 
enzyme cinnamyl alcohol dehydrogenase in maize has been shown to reduce lignin levels and 
thus produce a higher amount of biomass and a higher level of cellulosic ethanol in assays 
(Fornalé et al. 2012).  
 
Future sustainable biofuel systems are more likely to rely on high yielding ligno-cellulosic 
feedstocks, rather than the current oily, starchy or sugary feedstocks. This should ease the 
tension created by direct use of foodstuffs, improve land use efficiency (particularly as these 
can be supported on lower grade land) and add flexibility of end-use options(Thornley 2012). 
The most likely European woody biomass crops are willow and Miscanthus; but GM 
technology to improve these is not expected to be commercialized in the next decade. 
Judgements will be needed on the best use of the biomass given its suitability for conversion 
to heat, electricity, transport fuel or renewable chemicals. 
 
C. GM traits for developing countries 
 
Many of the traits described above (improved photosynthesis, and tolerance to acid/saline 
soils and drought) could be useful worldwide. In particular, pest and disease control is a 
problem everywhere, and indeed, is more problematic for poor farmers who cannot afford 
pesticides or fungicides, or the equipment to safely deploy them. For example, a public-
private partnership between Syngenta and the International Maize and Wheat Improvement 
Center (CIMMYT) in Mexico will focus on the development and advancement of technology 
in wheat through joint research and development in the areas of native and GM traits, hybrid 
wheat and the combination of seeds and crop protection to accelerate plant yield performance. 
The partnership will leverage Syngenta’s genetic marker technology, and advanced traits 
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platform, along with CIMMYT’s access to wheat genetic diversity, global partnership 
network, and wheat breeding programme targeted at low-income countries. 
 
Some specific problems of the developing world that could be alleviated with GM traits are 
described below. 
C1. Nutritional enhancement (biofortification) – vitamin A, iron and zinc 
 
Micronutrient malnutrition, or hidden hunger, is caused by a lack of micronutrients in the diet 
and can result in blindness, stunting, disease and even death. Fruits, vegetables, and animal 
products are rich in micronutrients, but these foods are often not available to the poor who 
rely on a daily diet of inexpensive staple foods, such as rice or cassava, with few 
micronutrients. Enhanced nutrient content is a crucial goal in the light of the world’s growing 
population and the central roles of staple crops in human diets. Developing crop varieties with 
increased micronutrient concentrations is an approach known as biofortification, and much of 
this work has been carried out in rice. Similar studies and field trials are underway in banana 
and cassava (Welsch et al. 2010). 
 
Vitamin A is made in the human body from β-carotene, and vitamin A deficiency is the 
leading cause of irreversible blindness in children. The World Health Organisation estimates 
that this results in up to 500,000 children going blind per year, 250,000 of whom will lose 
their lives within a year. The problem is particularly severe in South East Asia. Rice is a 
staple food consumed by half the world population every day, but none of the existing 
cultivated varieties contain β-carotene in the grain. The International Rice Research Institute 
working with Asian farmers has developed locally adapted Golden Rice varieties, which 
produce β-carotene in their grain (giving the golden colour). Golden Rice was only possible 
as a result of genetic engineering developed in the late 1990s at ETH in Zurich by German 
Professors Potrykus and Beyer and a not-for-profit independent research institute (Golden 
Rice Humanitarian Board 2013). Fifteen years later Golden Rice is still not authorized for 
cultivation, to the dismay of scientists (Potrykus 2010). The β-carotene produced is of 
equivalent nutritional utility to other sources (Tang et al. 2012). This technology is also being 
applied to banana, and “Golden bananas” are undergoing field trials in Uganda. 
 
Over two billion people suffer from iron and zinc deficiencies. Biofortification of crop 
varieties with these micronutrients is challenging because metal ion concentrations in various 
tissues and compartments are maintained within narrow physiological limits by coordinated 
uptake, translocation and storage. Furthermore, for crops like rice, removal of the outer layers 
of the grain during polishing, removes many micronutrients, leaving only the starchy 
endosperm.  
 
Scientists are expressing key genes involved in the mobilization of micronutrients from the 
soil to the seed in rice through three different approaches: 1) enhancing iron translocation 
through overproduction of the metal chelator nicotianamine and phytosiderophores; 2) 
enhancing iron influx into the endosperm by means of the iron-nicotianamine transporter 
Oryza sativa yellow-stripe-like-2 (OsYSL2); and 3) enhancing expression of the iron storage 
protein ferritin. Combining 1) and 2) has resulted in greenhouse-grown rice with three- to 
fourfold higher levels of iron (Fe) in polished grain (Schroeder et al. 2013). Combining 1) and 
3) has increased the iron content more than sixfold; and combining all three approaches has 
resulted in paddy-field- grown polished rice with Fe concentrations 4.4-fold higher than those 
found in non-transgenic seeds, with no yield penalty. Although these results bring iron levels 
close to those recommended by nutritionists, only a handful of studies have tested whether 
these enhanced levels of nutrients are available on consumption. Enhancing the nicotianamine 
concentration does increase the levels of bioavailable iron and zinc in polished rice. 
  
Vacuolar sequestration also enhances the concentrations of iron and zinc (Zn) in seeds. Metals 
are transported between the cytoplasm and the vacuole by transporters, including the 
Arabidopsis vacuolar iron transporter VIT1 protein, which is highly expressed in developing 
seeds and transports iron and manganese. Disruption of the rice VIT orthologues (OsVIT1 
and OsVIT2) increases Fe/Zn accumulation in rice seeds and decreases Fe/Zn in the source 
organ flag leaves. Metal tolerance protein 1 (MTP1) also transports divalent cations into the 
vacuole. Thus several strategies are being used to enhance iron and zinc micronutrients in 
edible plant tissues, but more improvements are needed using our increasing knowledge of the 
transporters that take up micronutrients from the soil, such as iron-regulated transporter 1 
(IRT1), the major entry point for Fe in many plant species.  
C2. Banana diseases 
 
There are four major pests and diseases of banana: 
o Black Sigatoka, caused by Mycosphaerella fijiensisis controlled by enormous fungicide 
application rates- usually from aeroplanes over plantations, with limited efficacy. 
Credible GM strategies for resistance are underway but of unproven effectiveness. 
o Xanthomonas bacterial disease causes considerable losses in bananas in Central Africa. 
Credible GM solutions exist from expression of a sweet pepper-derived gene (Tripathi 
et al. 2010) but still need to be tested further. 
o Nematode infection of roots also suppresses yield. A collaboration between University 
of Leeds with Uganda has led to nematode-resistant bananas (Roderick et al. 2012), 
which are being grown in field trials (Figure 12). 
o A new strain (tropical race 4, TR4) of Fusarium oxysporum f. sp. cubense has emerged 
that causes Panama disease on the widely-planted Cavendish variety, which was 
previously resistant. Solutions, GM or otherwise, are awaited (Ploetz 2005).   
 
 
 
Figure 12. Field trial of GM banana at the National Agricultural Research Organisation 
in Uganda. 
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 C3. Bt brinjal /eggplant /aubergine 
 
In India and the Philippines, Solanum melongena (aubergines, eggplant or brinjal) is an 
important crop, but very susceptible to losses from lepidopteran insects such as the brinjal 
Fruit and Shoot Borer (FSB), Leucinodes orbonalis, and the Fruit Borer Helicoverpa 
armigera. Control of these pests is currently only achieved by extensive use of insecticides. 
GM Bt brinjal has been developed by Mahyco Seed Company (affiliated to Monsanto) by the 
introduction of a Bt gene (Cry1Ac) and is fully resistant to FSB. Permission is being sought 
for deployment, but has not yet been granted. Recently, Bt brinjal has been approved for 
cultivation in Bangladesh and is expected to be grown commercially next year. 
C4. Bt cowpea 
 
Cowpea (black-eyed peas) is the most important indigenous African legume (especially for 
small-scale, low-income farmers) due to its ability to grow in drought-prone areas and 
improve soil fertility. However, losses to pod-boring insects can be severe, with the cowpea 
pod borer (Maruca vitrata) causing yield losses as high as 70-80%. Insecticides against the 
Maruca pod borer exist but have not been widely adopted by farmers due to prohibitive costs 
and significant health hazards. GM BT-resistant cowpea has been developed by an 
international agbiotech public-private partnership (PPP) coordinated by the African 
Agricultural Technology Foundation (AATF), a not-for-profit organization that facilitates and 
promotes PPPs for the access and delivery of appropriate agricultural technology for 
sustainable use by smallholder farmers in sub-Saharan Africa. Monsanto donated the Bt gene 
to AATF on a humanitarian basis under a royalty-free license. The Institute for Agricultural 
Research (IAR) in Zaria, Nigeria is responsible for the Bt cry1Ab gene introgression into 
local cowpea varieties. Field-testing was then carried out in specific locations in Nigeria 
(Ezezika & Daar 2012). Deployment is expected by 2017. 
C5. Cassava diseases 
 
A major challenge for cassava farmers are cassava mosaic virus and cassava brown streak 
virus. Research funded by the Gates Foundation is exploring the use of RNAi against these 
viruses to reduce susceptibility (Taylor et al. 2012) (Figure 13). In addition, Xanthomonas 
bacterial disease of cassava can also cause extensive losses (Bart et al. 2012), and GM disease 
resistance traits being developed are likely to be available in the short/medium term. 
 
  
 
Figure 13. Sections of cassava roots from conventional variety (left) and GM brown 
streak virus resistant material (right) (Photos from NEPAD). 
 
 27
  28
D. New enabling techniques and methods 
D1. Synthetic biology 
 
Many of the opportunities highlighted above (C4 rice, nitrogen-fixing wheat, avenacin-
producing wheat) are now technically feasible due to the availability of new methods in 
synthetic biology, gene synthesis and multigene vector cloning. 
 
New methods greatly facilitate assembly of T-DNAs that carry many genes (Weber et al. 
2011), enabling assembly of complex biosynthetic pathways to enhance plant performance. 
This type of “Synthetic biology” offers a major new opportunity and extraordinary potential 
for breeding GM crops. If multiple genes can be delivered into a plant at one locus and confer 
multiple traits (herbicide, insect, disease, stress resistance, and nutritional enhancement), plant 
breeding would be greatly simplified compared to current breeding methods where each trait 
is delivered in distinct GM events with inserted DNA at different chromosomal locations, 
which then segregate independently during breeding.  
 
Many pests are specialized to cope with the chemical defences of their plant hosts, and plants 
engineered to produce the chemical defences from a different plant may have increased pest 
resistance. An early example of the opportunities in this kind of engineering was elevation of 
insect resistance in Arabidopsis by delivering three enzymes for the biosynthesis of the 
sorghum-derived cyanogenic glycoside dhurrin (Tattersall et al. 2001). 
 
Adding multiple genes to a crop in one GM event provides a challenge for the current EU 
regulatory framework, and potentially means GM crops developed by these new methods 
could not be deployed. For example, individual toxicity tests need to be carried out on each 
added protein, even if it has been part of the diet in a non-transgenic plant. 
D2. High throughput sequencing technologies 
 
One of the most important bio-technological developments in the last ten years, together with 
advances in bioinformatics, is the availability of high throughput DNA sequencing methods at 
very affordable prices. These techniques allow the production of Gigabases of DNA 
sequences for around US$1000, and as a consequence, the amount of information present in 
DNA databases has doubled every 18 months (Figure 14). 
 
As a result of these high throughput methods, the genome sequences of the main plant species 
are now known (Figure 15). The resulting datasets include the genomes of model species, 
such as Arabidopsis thaliana, those of the main crops - rice, maize, and soybean, and other 
important species such as poplar, cotton, grapevine, apple, cassava and sorghum. 
 
At the same time, the genomic variation within a species is becoming accessible due to 
resequencing of different breeding lines (cultivars). In the case of Arabidopsis but also rice, 
more than 1000 sequences from different cultivars have been obtained and published (1001 
Genomes Project n.d.; Huang et al. 2012). This genome sequence data is helping to identify 
the genetic basis of domestication of the main crop species, and the many major genes 
affecting the performance of crops, including yield and disease resistance. Progress is also 
being made towards the identification of minor genes affecting quantitative traits that would 
have been more difficult to identify using classical molecular biology and genetics. 
 
The same technologies applied to collections of microorganisms allow metagenomic analysis 
of the species populating oceans (Venter et al. 2004), soils, human or ruminant intestine and 
 other environments. These data are generating information about large numbers of microbial 
genes. 
 
The current and imminent innovations in GM crops described above in Sections 1 and 2A-C 
were developed in an era when DNA sequencing was slower and less efficient than at present, 
and it was relatively difficult to identify genes that control a particular trait. The availability 
of these large amounts of sequence data linked to innovations in bioinformatics has increased 
the potential list of traits for GM. It will extend beyond the list of traits dependent on single 
genes to those involving multiple genes. 
 
 
(Copyright Clearance Centre RightsLink® License Number 3335821433063) 
Figure 14. Comparison of the information present in databases and the price for 
sequencing in relation to the human genome (Lupski et al. 2010).  
 
D3. Directed methods for producing mutations and for plant transformation 
 
Genetic variability relies on the continuous production of gene variants within a population of 
a given species, through different mutagenic processes. In order to accelerate breeding, 
mutagenesis has been applied to crops using similar methods, based on the action of radiation, 
chemicals or the insertion of transposons and T-DNA. These methods essentially act at 
random and a subsequent search is needed to identify the desired mutants within a population 
of plants. The approaches of reverse genetics consist in looking for mutants in a gene of 
interest, with methods such as tilling(McCallum et al. 2000) developed to detect mutations in 
any gene of a plant. Genetically modified plants have been developed as an alternative to 
mutagenesis that enables completely new traits to be established in a plant. 
 
New methods to produce genetically-modified plants have increasingly been developed 
during the last five years that enable mutations at very specific locations or to target gene 
sequences at specific sites. Classical methods of GM cannot predict the location of the new 
gene in the plant genome, and the insertion may cause the new gene to have low levels of 
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 expression or to insert into another useful gene. The targeted GM methods in contrast insert 
the new gene in a specific location to avoid unforeseen effects.  
 
 
 
Figure 15. Sequences of plant genomes available in 2013 in Phytozome, a database for 
public plant genomes (Goodstein et al. 2012). 
 
These new methods are based on the use of site-directed nucleases (SDN) (Podevin et al. 
2013) (Figure 16) to prepare the target site DNA for modification or insertion of a new 
sequence. Two examples of SDNs are Zinc-finger nucleases and TAL-nucleases in which a 
hybrid protein comprises a nuclease domain from a bacterium to cleave DNA and a sequence-
specific DNA binding domain with a motif from a plant pathogen Xanthomonas. The SDN is 
expressed in cells of the crop to be engineered by a break at a defined location in the genome, 
where a mutation or foreign DNA can be introduced. 
 
Other SDN systems include: 
 
 The Cre-lox recombination system - a bacterial system directing the insertion of genes to a 
sequence that has been previously introduced in the genome (Gilbertson 2003).  
 
 CrispR-Cas9 gene disruption system - using RNA sequences to direct the Cas9 nuclease to 
a specific DNA sequence has recently been shown to efficiently produce targeted 
mutations in plants (Nekrasov et al. 2013) and even in primates (Niu et al. 2014). 
These directed methods for GM are very new and have not yet had a big impact on practical 
application. However, in one example a TAL –nuclease was used to introduce a mutation in a 
plant gene that is normally harnessed by pathogenic bacteria when they infect a plant and 
cause disease. TAL nucleases are based on bacterial transcription Factors (called TAL 
effectors) which when transferred into the plant activates plant genes. The TAL nucleases 
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targeted to one of these genes was used to introduce mutations in “susceptibility genes” 
resulting in resistance to Xanthomonas bacterial blight (Li et al. 2012).  
 
 
Figure 16. Mode of action of Site-Directed Nuclease (EFSA opinion) (EFSA GMO Panel, 
2012). 
Methods using SDNs are likely to become the normal method of GM. This change from 
current practice will have practical and regulatory consequences. At the practical level these 
methods will allow: 
 
 GM at defined sites in the genome that favour transgene expression, reducing the need 
to screen multiple GM lines for those in which the transgene is expressed. 
 
 targeted mutation of a specific gene; this is useful if the target gene encodes a gene 
that adversely affects the yield or quality of a crop. 
 
 replacement of an endogenous gene with a similar but improved version from a related 
species or one that has been modified in vitro using knowledge of the gene’s function. 
 
 insertion of a completely novel gene into a site in the genome that is known to favour 
foreign gene expression and where there is no effect on expression of other genes.  
 
 insertion of “cassettes” that contain multiple genes allowing the introduction or 
modification of complex traits such as metabolic pathways in a single step, and 
placement of the whole set of genes in the same locus in the plant avoiding any effect 
from multiple insertions of new genes in different places in the genome. Multi-gene 
cassettes of up to 24 genes can be assembled using GoldenGate or Goldenbraid 
systems (Weber et al. 2011; Sarrion-Perdigones et al. 2011).  
 
These new methods will also have regulatory consequences for GM crops. They will, for 
example, facilitate characterisation of the transgene insert in any one line because the site 
of insertion will be known, and this will negate the criticism of GM crops that insertion of 
DNA is currently random with “potentially unforeseeable consequences”. In addition, 
these methods will eliminate the need to introduce a selectable marker gene together with 
the useful insert of a GM crop. In extreme instances the difference between a targeted GM 
and an equivalent non-GM line will be as little as a single nucleotide, and the practical 
distinction between GM and non-GM lines will be blurred.  
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Part 3: Safety and risk assessment 
Summary 
 
 Experimentation and commercial release of GM crops is subject to considerably 
more stringent regulation than are conventionally bred plants. There are similar 
stringent frameworks in other countries but the approval process is more 
streamlined and effective in the Americas and Australia. 
 
 The consequence of the regulatory process for commercial release adds between 
€10 and 20 millions to the cost of developing a new GM variety – an amount that is 
prohibitive for small and medium sized enterprises and the public sector. Large 
multinational companies have withdrawn their research effort to develop GM crops in 
Europe because the approval process operates slowly and inefficiently. Also, there is a 
consequence for research, in the significant reduction in number of experimental field 
trials in the UK with only one field trial in 2012, compared with 37 in 1995. 
 
 EASAC and others have pointed out that there is no rational basis for the current 
stringent EU regulatory process. There are no reliable data indicating inherent risk 
for human or animal health, for the environment or from unforeseen effects.   
 
Introduction 
 
Section A provides details on the different regulatory frameworks for GM crops in the EU 
and other countries; while Section B explores the consequences of the EU regulatory 
framework on the development of GM crops for Europe; and Section C reviews the scientific 
evidence available to assess the risks of GM crops to human or animal health, and the 
environment.  
 
A. Regulation of GM crops in the EU and elsewhere 
 
Growing GM crops in the EU is controlled by two pieces of EU legislation: 
 
o Part B of Directive 2001/18/EC (the ‘deliberate release’ directive) is used to regulate 
field trials on a national basis; and 
 
o Regulation 1829/2003/EC (the ‘GM food and feed regulation’) is used to control the 
commercial cultivation of GM crop plants and operates at the EU-level.  
 
Both sets of legislation adopt the same basic principles i.e. that each GM crop should be 
assessed on a case by case basis and decisions on whether to authorise their use should be 
founded on an assessment of the risks to human health and the environment. Benefits are not 
taken into consideration in the assessment. The legislation requires indirect effects (e.g. the 
consequences of gene flow to sexually compatible wild species or to bacteria in animal guts) 
as well as direct effects (impacts on organisms that come into contact with the GM crop) to be 
taken into account. It also requires delayed (e.g. the evolution of insect resistance) as well as 
immediate effects to be assessed. Post-market environmental monitoring (PMEM) of every 
GM crop authorised for commercial cultivation must be carried out to look for unforeseen 
impacts. Table 5 summarises the safety assessment of GM crops in the EU. 
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The EU’s approach to assessing the safety of GM crops is widely viewed as the most stringent 
system in the world. Applicants are required to submit risk assessments, risk management 
options and plans for PMEM. This information is scrutinised by experts in the 28 EU member 
states and by the Commission’s expert advisory committee on GMOs (EFSA GMO Panel, 
2013). The assessment process also includes public consultations.  
 
Table 5. Overview of studies required for the safety assessment of GM crops in the EU. 
(Raybould & Poppy 2012). 
 
Safety Area Safety Study Performed Safety Parameter Measured 
Molecular 
characterization 
Southern and sequence analysis to assess 
where the gene has been inserted into the 
plants DNA. 
Southern analysis to assess the stability of 
the insertion over multiple generations. 
Sequencing of the inserted gene. 
Sequencing of the insertion site. 
Bioinformatic searches. 
To check what DNA has been inserted into 
the plant and to ensure this insertion is stable 
over multiple generations. 
To check no essential gene has been disrupted 
and that no unintended genes have been 
created. 
Protein 
expression 
Protein expression of the introduced protein 
over multiple generations. 
Protein expression of the introduced protein 
during development of the plant. 
Protein expression in plants grown at 
different locations.  
To show that the protein is stably expressed 
over multiple generations. 
To assess levels of exposure to humans and 
the environment from field trials performed at 
different locations. 
Protein toxicity 
and 
allergenicity 
studies. 
Stability studies. 
Acute toxicity in mouse (high dose). 
Repeat dose toxicity study. 
Homology searches to known 
toxin/allergens. 
Allergencity studies (sera studies performed 
on a case by case basis). 
Ecotoxicology studies on a wide range of 
non target species (for cultivation, mainly 
for insect tolerant proteins). 
To assess stability to gastric fluid. 
To assess stability to processing. 
To check the protein is not toxic. 
To ensure there are no homologies to known 
toxins or allergens. 
To assess the toxicity to non-target organisms 
(cultivation only). 
Compositional 
and phenotypic 
analysis 
Compositional analysis. 
Phenotypic (agronomic) analysis. 
To compare the GM to the non GM plant to 
assess if there are difference and if the 
differences are likely to be of biological 
relevance (compared to ranges of 
commercially grown plants). 
Whole plant 
studies 
Comparative analysis (as described above). 
Protein expression (as described above). 
90 day rat study (case by case basis). 
Processing study. 
Ecotoxicology studies on plant material (for 
cultivation, for all traits). 
Processing study. 
Ecotoxicology studies on plant material (for 
cultivation, for all traits). 
Non-target organism field studies. 
To assess the safety of the whole plant and the 
likelihood of adverse effects. 
Supporting 
information 
Event specific detection method. 
Certified reference material. 
Unique identifier. 
Post market monitoring plan. 
Event specific detection method to distinguish 
the event from other events. 
Reference material is required as part of the 
detection procedure. 
Unique identifier is the unique code for the 
event. 
A post market monitoring plan is required in 
the EU to monitor for unanticipated adverse 
effects or to confirm the risk assessment. 
(Copyright Landes Bioscience) 
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Whereas the regulatory framework is broadly similar to other countries e.g. Australia, Brazil 
and Argentina, it has been less efficient in processing applications to commercially cultivate 
GM crops. Since the system was adopted in 1990, only three decisions1have been taken in the 
EU; and only one since 1998. The latter was for a GM potato with altered starch content 
(EH92-527-1) authorised in 2010, but only grown on a very limited scale before commercial 
cultivation was suspended due to difficulties for the Company (BASF) associated with 
operating in the EU. Approximately 20 applications for commercial cultivation have been 
submitted to EU regulators over this period, with most of these held in the regulatory pipeline 
for at least five years. Applications to commercially cultivate two types of GM insect resistant 
maize (Bt11 and 1507), have been in the system the longest, with submissions in 1996 and 
2001 respectively. This situation compares with Australia, which has authorised the 
commercial cultivation of 12 GM crops since 2002, five of which have since been 
surrendered (AU Department of Health 2013). The USA with a different system has approved 
the commercialisation of 96 GM crops since 1990 (See section A4). In a recent decision 
(November 2013) the General Court of the European Union ruled against the European 
Commission for not presenting to the Regulatory Committee a proposal to allow a GM maize 
from the seed company Pioneer (maize 1507) that was submitted in 2001 and approved by 
EFSA in 2005. As a consequence the European Commission has remarked on the inability of 
member States to agree to a process that would allow each one of them to take their own 
specific decision.  
 
B. The consequence of a stringent EU regulatory framework 
 
Compliance with the GM regulatory system, based on the costs for a GM insect resistant 
maize in the USA, is estimated to add €5.5-11.5M to the cost of developing a new GM crop 
relative to a non GM variety. Costs in the EU may be higher2, particularly since GM crop 
approvals in the EU must be renewed at least every 10 years (See Tables 5 and 6). 
 
This regulatory burden is prohibitive for all but large companies (EASAC 2013) and only 
certain crop/trait combinations are economically viable if they rely on seed sales to capture 
profit. Otherwise, regulatory costs need to be vertically integrated into the production of a 
high value product (e.g. Del Monte’s pink-fleshed GM pineapple grown in Costa Rica, which 
will be imported into the USA once USDA approval is received). In general, these two routes 
for capturing profit to offset regulatory and development costs do not exist in developing 
countries.  
 
Even large multinational corporations experience difficulties with the EU regulatory process. 
BASF and Monsanto withdrew applications to commercially cultivate GM crops and have 
closed down their GM crop programmes in the EU this year. The result is that only one GM 
crop (another insect resistant maize) has been cultivated on any significant commercial scale 
in the EU (see section A3). 
 
The overly burdensome and slow regulatory framework means that Europe is losing out to 
international competition in the development and use of GM crops, most notably from the 
Americas and China. It is also moving away from a knowledge based bio-economy and losing 
international competitive advantage (EASAC 2013). 
 
 
1T25 maize (tolerant to glufosinate ammonium herbicides), BASF’s Amflora potato and MON810 maize. 
2There have been no authorisations of equivalent GM plants since 1998. 
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The number of GM crop field trials in the UK has decreased dramatically since the 1990s, 
with typically only one or two applications in recent years. In 1995, there were 37 
applications to trial GM plants in the UK (compared with 684 in the USA and 213 in the EU). 
In 2012, one field trial application was received in the UK (compared with 664 in the USA 
and 45 in the EU). 
 
Table 6. Compliance costs for insect-resistant maize (Kalaitzandonakes et al. 2007). 
 
Cost categories Range of costs incurred 
($) 
Preparation for hand-off of events into regulatory 20,000–50,000 
Molecular characterization 300,000–1,200,000 
Compositional assessment 750,000–1,500,000 
Animal performance and safety studies 300,000–845,000 
Protein production and characterization 162,000–1,725,000 
Protein safety assessment 195,000–853,000 
Nontarget organism studies 100,000–600,000 
Agronomic and phenotypic assessments 130,000–460,000 
Production of tissues 680,000–2,200,000 
ELISA development, validation and expression analysis 415,000–610,000 
EPA expenses for PIPs (e.g., EUPs, tolerances) 150,000–715,000 
Environmental fate studies 32,000–800,000 
EU import (detection methods, fees) 230,000–405,000 
Canada costs 40,000–195,000 
Stewardship 250,000–1,000,000 
Toxicology (90-day rat)—when done 250,000–300,000 
Facility & management overhead costs 600,000–4,500,000 
Total 7,060,000–15,440,000 
ELISA, enzyme-linked immunosorbent assay; EPA, US Environmental Protection Agency 
(Washington, DC); EUP, experimental use permit; PIP, plant-incorporated protectant. 
(Copyright Clearance Centre RightsLink® License Number 3335831176883) 
 
Extraordinarily, in Romania before they joined the EU, GM soybeans were extensively grown 
and exported to Europe. Since they joined the EU, Romania is now forbidden to grow GM 
soy as it is not authorized for cultivation in Europe. Instead, the EU pays farmers in Brazil, 
Argentina and US to grow GM soy, and provides subsidies to Romania from regional funds. 
 
The costs of regulation and the delays associated with having to gain all necessary approvals 
for GM crops, also have impacts outside the EU. In particular, they deter innovation and 
technology transfer in the public sector and in developing countries. An economic study of 
GM eggplant, tomato, rice and papaya showed that a three year delay in reaching the market 
reduced the Net Present Value of these products by between 34% and 93% (Falck-zepeda et 
al. 2012). 
 
C. Is GM regulation necessary? 
 
A special GM crop regulatory process would be justified if GM technology is especially 
dangerous. If, for example, it introduced inherent risks to human or animal health, the 
environment or if the technology is so poorly understood that there are extraordinary 
uncertainties then special measures would be required that do not apply to crops improved by 
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conventional breeding. In this section the scientific evidence is reviewed to consider these 
possibilities. 
C1. Human and animal health 
 
There are a few high profile and controversial studies that claim to refute positive assessments 
of GM crops. For example, a study by Séralini et al concluded that a herbicide-tolerant maize 
caused tumours and early death in rats (Séralini et al. 2012), but this was widely dismissed by 
scientists not involved with the study, including EFSA (European Food Safety Authority 
2012). In November 2013, this article was retracted by the journal concerned (Elsevier, 2013). 
Séralini had published other papers linking health risks to GM food/feed previously (Séralini 
et al. 2007). In each case, the scientific community and food safety authorities found that that 
the evidence did not support the conclusions. There are other examples of this type where 
claims have been made based on poor science (e.g. (Ewen & Pusztai 1999); (Carman et al. 
2013)). In other cases, claims are based on hypotheses that harm could occur under certain 
scenarios. For example, Zhang et al., 2012 suggested that plant-derived RNA might transfer 
from plant-based feed and have regulatory effects on genes in animal organs (Y. Zhang et al. 
2012; L. Zhang et al. 2012). Despite the fact this phenomenon has been described for non-GM 
plants, it has formed the basis for claims (Heinemann et al. 2013) that transgene RNAs 
(dsRNAs) create biosafety risks which are not being adequately assessed by regulators. 
 
Snell et al. reviewed 24 studies of the health impacts of GM and found that there were no 
statistically significant differences between GM and non-GM crops within the parameters 
observed (Snell et al. 2012). Other studies have been inconclusive about risks associated with 
health (Domingo & Giné Bordonaba 2011). Notably, even in the highly litigious USA, there 
have been no successful lawsuits, no product recalls, no substantiated ill effects, and no other 
evidence of risk from a GM crop product intended for human consumption since the 
technology was first deployed commercially in 1994 (Masip et al. 2013).  
C2. Environmental damage 
 
One of the prominent concerns about GM crops is that their release into the environment 
“releases the genie out of the bottle”. Like alien species, it is feared, the GM crops or their 
genes will invade and damage existing ecosystems and once released, it will be difficult to 
eliminate them. However, as described below, there is no evidence or justification for this 
fear, as any observed environmental effects of GM crops are no different to those experienced 
with equivalent conventionally bred crops. 
 
There is no question, for example, that widespread cultivation of GM herbicide (glyphosate) 
tolerant crops in the US has selected for herbicide tolerant weeds. However, this is not due to 
the GM crop per se, but the crop protection regimes relying on glyphosate used by farmers, 
and the result would be the same for conventionally bred plants had they been cultivated on 
the same scale with limited herbicide rotation. Once the herbicide-tolerant weeds are present 
in both conventional and GM crops, and the usefulness of glyphosate is compromised, 
farmers need to apply higher levels of herbicide or rotate other products or use new and 
different integrated weed protection strategies (Heap 2013).  
 
It is likely that cultivation of herbicide tolerant GM crops does have an effect on the 
biodiversity of agricultural ecosystems, as their use allows for highly effective weed control 
so the cultivated environment contains fewer plant species with inevitable consequences on 
other layers of the ecosystem in that environment. There would be the same effect with 
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herbicide tolerant crops produced by conventional breeding, and moreover, there is evidence 
to demonstrate how this effect can be mitigated (Pidgeon et al. 2007).  
 
Conversely, there is evidence that demonstrates that the use of herbicide tolerant GM crops 
has resulted in a number of environmental benefits, such as reduced greenhouse gas 
emissions, reduced soil tillage and associated nutrient loss, and the use of more benign 
herbicides which degrade quicker in the environment (Brookes & Barfoot 2013b).  
 
An early scare with GM maize producing insecticidal (Bt) proteins was of claimed damage to 
non-target insects including Monarch butterflies (Losey et al. 1999). Whilst ongoing research 
is still trying to pinpoint the precise cause of the insect decline, a large body of peer-reviewed 
work on Monarch butterflies and Bt corn was published in the Proceedings of the National 
Academy of Sciences (Sears et al. 2001). These studies concluded that populations of 
monarch butterflies would not be significantly affected by the cultivation of this GM maize. A 
separate Chinese study reported that the use Bt transgenic crops including rice, with reduced 
applications of systemic insecticides led to increased levels of non-target insects and 
protection for farmers applying less of the toxic chemicals (Huang et al. 2005; Chen et al. 
2011). However, these effects were not generic effects of GM but consequences of the trait 
and would have arisen both with GM and non GM traits. 
 
Pollen-mediated gene transfer from GM crops to sexually compatible weeds and wild 
relatives is frequently conjectured as a hazard of GM crops, as it is considered likely that the 
transgenes with major effects in the GM crop will have similar effects in weeds (Warwick et 
al. 2009). However, gene flow between plants is a natural phenomenon with both GM and 
non GM crops especially with wild or weedy relatives. A few research studies have been cited 
as evidence that gene flow from GM crops results in so-called ‘super weeds’. In a three year 
study in the UK, researchers claimed to have found two hybrid plants resulting from the 
cross-pollination of charlock with GM herbicide tolerant oilseed rape (Hopkin 2005); one was 
sterile and the other did not survive so could not be analysed fully to determine the true 
hybrid status.  Snow et al. crossed a weedy relative with GM sunflowers that expressed an 
insecticidal protein, and the resulting GM plants produced more seed than their non-GM 
counterparts, but it was unclear whether this would increase fitness under field conditions 
(Snow et al. 2003). The only report of the occurrence of ‘super weeds’ resulting from the 
commercial cultivation of GM plants was in Canada, where cross-pollination between GM 
oilseed rape plants containing different herbicide tolerance genes resulted in plants with 
tolerance to multiple herbicides. This effect has also been observed with conventionally bred 
herbicide tolerant plants, and since 2004, stewardship plans have included strategies to reduce 
multiple herbicide-tolerant volunteer rape. These include measures such as post-harvest 
tillage, appropriate crop rotation, use of certified seed and wherever possible avoiding, 
successive cultivations of varieties with different herbicides tolerances (Beckie et al. 2006).  
 
Agriculture is an environmentally invasive activity with ecosystem effects that may be as 
profound as with any other industry. These various examples with GM crops illustrate the 
need to manage innovation in agriculture, but that this management should be no greater with 
GM than with any other type of crop. The use of herbicide tolerant crops of both GM and non 
GM types, for example, should be managed to mitigate selection of herbicide tolerant weeds. 
Similarly as disease-resistant GM crops are developed, as with non GM types, their use needs 
to be managed to prevent selection of pests and pathogens able to overcome the resistance.  
 
A good example of such a management strategy is with Bt insect resistant GM crops that have 
been grown alongside reservoirs of non GM crops providing refuges where the insect pests of 
the crop can persist in the agricultural environment so that selection pressure for Bt resistance 
is minimised (Gould 1998). This strategy has mostly been successful until now and similar 
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strategies could be developed for other types of disease resistance. Indeed, the application of a 
refuge strategy could have increased the durability of non GM forms of disease resistance. 
The history of plant breeding includes many examples of good disease resistance genes that 
have been rapidly overcome by the pathogen once they were grown widely without attempts 
to mitigate selection of resistance-breaking forms. A refugia policy is only successful with 
farmer compliance (Tabashnik et al. 2013; Kruger et al. 2009; Kruger et al. 2012; Dangl et al. 
2013). 
C3. Unknown unknowns 
 
GMO-sceptics continue to claim that GM crops are harmful because they are likely to contain 
more unintended changes to their DNA compared with plants produced by traditional 
breeding techniques (van den Belt 2003). Extensive use and study of GM plants since the 
EU’s GMO legislation was put in place, demonstrates that this is not the case. The objective 
of plant breeding in general is to generate genetic variation and to select variants with 
desirable characteristics. Consequently, plant breeding produces a vast number of off-types 
that have to be discarded during the process of producing a new variety.  
 
New technologies are being developed that aid precision and thereby efficacy, both in GM 
and non-GM plant breeding e.g. site-specific insertion of DNA and site-directed mutagenesis. 
This goal has been facilitated by dramatic advances in genomics (Section 2D). Genome 
sequencing projects have demonstrated the extreme plasticity of plant genomes (Bevan 2011; 
Weber et al. 2012). Given the high degree of natural plasticity and variability between 
genomes and epigenomes of individuals of the same species as well as within any single 
individual, focussing on differences between genomes in regulatory assessments is not 
helpful, unless the significance of difference is understood and is meaningful in terms of the 
observable physical or biochemical characteristics of the plant (as determined by both the 
genetic make-up and environmental influences).  
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Part 4: Conclusions and recommendations 
Summary 
 
 GM crops have the potential to contribute substantially to advances in 
agriculture that are necessary to achieve sustainable and sufficient global food 
production in the face of challenges from population, climate change, and 
environmental degeneration. Conventional plant breeding is not likely to meet this 
challenge and cannot take advantage of innovation in synthetic biology. 
 
 To realize the potential of GM crops, the R & D pipeline needs to be strengthened 
and the European regulatory process improved.  
 
 The R & D pipeline would benefit from a programme that promotes preliminary 
evaluation in the field of the practical potential of genes defined in academic 
laboratories that could be useful in crops. This programme referred to as PubGM 
would enable and facilitate field testing of new GM crops either in partnership with 
companies or so that the public sector could validate traits before commencing 
partnerships with companies. 
 
 Many new plant breeding techniques developed since the EU GMO definitions were 
adopted in 1990, were not foreseen, and some plants with a particular novel trait will 
be captured by the legislation, whilst others will not. Given that there is no evidence 
for intrinsic risks associated with GM, it is not useful to have a regulatory framework 
that is based on the premise that GM crops are more hazardous than those produced by 
conventionally bred plants. As proposed by EASAC, a future regulatory framework 
should be product rather than process based so that it is consistent and applies to 
the novelty of the characteristics of new plant varieties. 
 
 Approval for commercial cultivation should be made on a national level as 
happens at present with pharmaceuticals. This would safeguard against potential 
losses and damage to European agriculture that follow from the failure to adopt GM 
crops, and enable appropriate regulation of new technologies such as genome editing 
and synthetic biology for crops, 
 
Introduction 
 
The first two sections of this report illustrate how the advances in GM science for crop 
improvement promise effective ways to develop GM crops that improve the efficiency of 
agricultural production by protecting or increasing crop yields, combating the damaging 
effects of unpredictable weather and disease on crops, reducing fertiliser and chemical use, 
and reducing losses to pests and disease, both before and after harvest. Equally important is 
the benefit from using cultivated land more efficiently, to provide more space for biodiversity, 
nature and wilderness. Research at Rockefeller University suggests that over next 50 years 
new technology, combined with improved agricultural practices across the world, could 
release an area 2.5 times the size of France from agricultural cultivation (Asubel et al. 2013). 
 
Increasing crop productivity solely from conventional plant breeding is becoming more 
difficult. Meeting the global challenges of food security in the context of increasing 
population, economic growth, predictions of faster climate warming, biodiversity action plans 
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and farming and environmental regulations will be tough. We need every tool in the toolbox 
(The Royal Society 2009). 
 
To realise the potential of GM crops we propose strengthening the crop science research and 
development pipeline in the UK and modifying the regulatory process for GM crops at the 
EU-level. 
A. Research and Development 
 
The UK has world leading basic research in plant genomics (both GM and non-GM), but this 
is not currently being exploited to its best advantage to enable the commercial crop breeding 
sector to respond to these challenges. A well-functioning R&D pipeline is essential for the 
translation of genomic research through the pre-breeding stage into the development of crop 
varieties for the marketplace. However, the current pipeline in UK crop improvement fails to 
provide effective links between much needed innovation in crop breeding, investment in new 
technologies at the translational R&D stage, and public sector support in R&D. This failure is 
because the potential for profit in agriculture is more limited than in the parallel discipline of 
biomedicine, and commercial sponsors or investors are less likely to adopt crop improvement 
programmes, unless there is sufficient evidence that laboratory findings will translate into 
commercial crops in the field.  
 
There are two interlinked R&D pillars needed to strengthen the pipeline in UK crop 
improvement using GM. 
A1. Public Enterprise GM (PubGM) 
 
Researchers in Universities and Institutes are continually discovering genes for promising 
crop traits, often using experimental species (see Section 2). Assessing the commercial 
potential of these discoveries is beyond the reach of standard academic laboratories. The costs 
are high both for field trial regulation and to support the field scale infrastructure. The 
likelihood of commercial reward is too low at early stages to gain commercial backing. 
Therefore new approaches are needed to realize the value of the backlog of innovations from 
public and private sector scientists, and assess these available traits in UK varieties and 
environments within a standardized framework on GM trial plots for possible 
commercialization. In addition, PubGM could engage with the private sector and test 
“company traits” via contract research, and could make DNA constructs and multiple 
transgenic events that are screened, tested, selected for deregulation, assessed by DEFRA and 
FSA, and then returned to the private sector in return for a suitable license fee. It could also 
develop, test and deploy state-of-the-art genome editing and multigene T-DNA methods. 
Particularly useful events might be auctioned, resulting in revenues that could defray costs of 
the programme. This approach also has the benefit of generating data to assess the utility of 
GM approaches, enabling both consumers and regulatory authorities to make decisions about 
usefulness of particular GM traits in the UK, based on evidence. 
A2. Next­generation farm scale crop evaluation platforms 
 
Multiple factors, including pests and diseases, can strongly and adversely influence crop 
productivity. New methods are needed to understand these factors and their influence on 
diverse crop genotypes to guide science and inform breeding decisions. This knowledge 
directly underpins sustainable production and links breeders, growers and farmers with R&D 
in new productive ways. A small network of high precision, high throughput farm-scale crop 
assessment centres in the UK would develop a key new interface between academia, plant 
  41
                                                
breeders, producers and farmers to provide a platform for integrating multiple R&D activities. 
These include high precision remote sensing of the growing environment and crop growth, 
high-throughput and high precision assessment of new crop varieties produced by advanced 
breeding and GM methods, disease and epidemiology, soil science, different agronomy 
practices (e.g. organic/low input approaches), environment and biodiversity monitoring. 
Crops for food, forage, bioenergy, and novel biomaterials could all be assessed according to 
their different output traits. 
A fully optimised research pipeline for crop improvement would be reinforced by enhanced 
UK capacity in crop plant genomics that could be applied to both GM and non GM 
approaches. For crops where there is currently little or no market demand but where there are 
environmental or social benefits (for example new environmentally friendly varieties, or 
energy crops, break crops), the public sector will need to undertake the fundamental research, 
but may also need to develop it further to a more commercial stage. 
 
The Government’s recently published 'Agri-Tech' Strategy looks at how the UK can capitalise 
on its world-class science base by turning new ideas into practical applications. Crop 
improvement (and the role of GM) should be an integral component of the new Agricultural 
Innovation Centres proposed. 
B. EU regulation 
 
A number of recent reports have considered the suitability of the EU regulatory process 
(EASAC 2013; European Policy Evaluation Consortium (EPEC) 2011; ACRE 2013a). A key 
question is whether the EU should continue to adopt a regulatory framework based on how 
new plant varieties are generated (i.e. a ‘process-based’ approach) rather than on the novelty 
of their characteristics (‘product-based’ approach)3. This issue has become more prominent in 
recent years, as many new plant breeding techniques that have been developed since the GMO 
legislation was adopted in 1990 were not foreseen, and it is not clear whether the definition of 
a GMO applies to the plants produced by them. This uncertainty will increasingly inhibit 
innovation in biotechnology. EASAC and ACRE (UK Advisory Committee on Releases to 
the Environment) have questioned the scientific validity of a process-based approach to 
regulating novel plants. Inevitably it results in inconsistency; some plants with a particular 
novel trait will be captured by the legislation whilst others will not. In some of these cases, 
the plants produced by GM or conventional breeding may contain the same genetic alteration 
and have the same properties but only the GM version will be subject to regulation.  
 
Even if the EU were to adopt a ‘product-based’ approach to regulating crops with novel traits 
in the medium to longer-term, an efficient approach to risk assessment will be crucial. In 
discussing its experiences of working within the current GMO regulatory system, ACRE has 
highlighted concerns about how the system is implemented (ACRE 2013b; ACRE 2013c; 
ACRE 2013d). There is no consensus between EU regulators on what constitutes 
environmental harm and where there is no clearly defined risk hypothesis linking a 
characteristic of the GM crop to harm, information requirements are potentially open-ended 
and do not inform effective decision-making. This also results in assessments that lack 
perspective and confuse change with harm. The last three-yearly evaluation of the EU’s 
regulatory framework for GM crop cultivation (European Policy Evaluation Consortium 
(EPEC) 2011) made a number of recommendations for improving implementation of the 
 
3AThe Canadian Plant Biosafety Office (PBO) controls plants with novel traits (PNTs) regardless of the 
techniques used to produce them. This is the only example of a product-based approach to regulating 
novel crops. However, the assessment process is very similar to that of the EU’s i.e. it does not take 
benefits into account. 
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legislation, including restricting the number of requests for further information from 
applicants. There is also concern that the scientific risk assessment is being influenced by 
political considerations that do not have a scientific basis. For example, the EU has made 
animal feeding studies a requirement in GM crop risk assessments against the advice of its 
expert scientific advisory committee (Kuiper et al. 2013). 
 
It is unlikely that more than a handful of GM crops will be approved in the EU in the short 
term due to the dysfunctional approval process. One option to remedy this situation would be 
to continue with EFSA having an EU wide advisory role on risk and safety, but for approval 
of commercial cultivation to be made on a national basis. This would be similar to the current 
situation in pharmaceuticals, where the European Medicines Agency assesses new 
pharmaceuticals for humans and animals and, if they recommend use, a national decision is 
made by the National Institute for Clinical Excellence, the UK national competent authority. 
In the UK, decisions at a national-level to approve field trials of GM crops typically occur 
within statutory timeframes (3 months) and a related process could be used for commercially 
grown crops for which EFSA had made a positive recommendation. 
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